
Sabiha Naim Qazi
Examiner (ID: 9471, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1629, 1611, 1621, 1612, 1202, 1616, 1628, 1627 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8277312
[patent_doc_number] => 20120171183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'ARTHROPODICIDAL ANTHRANILAMIDES'
[patent_app_type] => utility
[patent_app_number] => 13/412659
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33477
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412659 | Arthropodicidal anthranilamides | Mar 5, 2012 | Issued |
Array
(
[id] => 9331171
[patent_doc_number] => 20140057953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'BIARYL DERIVATIVES AS SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/002784
[patent_app_country] => US
[patent_app_date] => 2012-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31012
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002784
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002784 | BIARYL DERIVATIVES AS SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 INHIBITORS | Mar 1, 2012 | Abandoned |
Array
(
[id] => 8382219
[patent_doc_number] => 20120225849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => '2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition'
[patent_app_type] => utility
[patent_app_number] => 13/408121
[patent_app_country] => US
[patent_app_date] => 2012-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5732
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13408121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/408121 | 2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition | Feb 28, 2012 | Abandoned |
Array
(
[id] => 8465670
[patent_doc_number] => 20120270839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/402023
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11555
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402023
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/402023 | Compositions and methods for cancer treatment | Feb 21, 2012 | Issued |
Array
(
[id] => 9199068
[patent_doc_number] => 20130338383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'PREGNANOLONE DERIVATIVES SUBSTITUTED IN 3ALPHA-POSITION WITH THE CATIONIC GROUP, METHOD OF THEIR PRODUCTION, USAGE AND PHARMACEUTICAL PREPARATION INVOLVING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/984320
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9883
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984320
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984320 | PREGNANOLONE DERIVATIVES SUBSTITUTED IN 3ALPHA-POSITION WITH THE CATIONIC GROUP, METHOD OF THEIR PRODUCTION, USAGE AND PHARMACEUTICAL PREPARATION INVOLVING THEM | Feb 14, 2012 | Abandoned |
Array
(
[id] => 8221665
[patent_doc_number] => 20120135866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'INCREASING PLANT VIGOR'
[patent_app_type] => utility
[patent_app_number] => 13/363827
[patent_app_country] => US
[patent_app_date] => 2012-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18158
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13363827
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/363827 | INCREASING PLANT VIGOR | Jan 31, 2012 | Abandoned |
Array
(
[id] => 11277028
[patent_doc_number] => 09493503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Certain chemical entities, compositions, and methods'
[patent_app_type] => utility
[patent_app_number] => 13/364191
[patent_app_country] => US
[patent_app_date] => 2012-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20539
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364191 | Certain chemical entities, compositions, and methods | Jan 31, 2012 | Issued |
Array
(
[id] => 8940483
[patent_doc_number] => 20130190280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Anti-Diabetic Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/354833
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4073
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354833
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/354833 | Anti-diabetic compounds | Jan 19, 2012 | Issued |
Array
(
[id] => 8199347
[patent_doc_number] => 20120122827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method'
[patent_app_type] => utility
[patent_app_number] => 13/352673
[patent_app_country] => US
[patent_app_date] => 2012-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7801
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122827.pdf
[firstpage_image] =>[orig_patent_app_number] => 13352673
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/352673 | Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method | Jan 17, 2012 | Abandoned |
Array
(
[id] => 8313853
[patent_doc_number] => 20120190871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/351775
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11895
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/351775 | TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | Jan 16, 2012 | Abandoned |
Array
(
[id] => 8160275
[patent_doc_number] => 20120101071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'SubstitutedTetracycline Compounds for the Treatment of Malaria'
[patent_app_type] => utility
[patent_app_number] => 13/338401
[patent_app_country] => US
[patent_app_date] => 2011-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101071.pdf
[firstpage_image] =>[orig_patent_app_number] => 13338401
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/338401 | SubstitutedTetracycline Compounds for the Treatment of Malaria | Dec 27, 2011 | Abandoned |
Array
(
[id] => 8141085
[patent_doc_number] => 20120095093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'ANTIFUNGAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/330349
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13201
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095093.pdf
[firstpage_image] =>[orig_patent_app_number] => 13330349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330349 | ANTIFUNGAL COMPOUNDS | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8430899
[patent_doc_number] => 20120252774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'STEROID TETROL SOLID STATE FORMS - 2'
[patent_app_type] => utility
[patent_app_number] => 13/328760
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23203
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328760 | STEROID TETROL SOLID STATE FORMS - 2 | Dec 15, 2011 | Abandoned |
Array
(
[id] => 8371169
[patent_doc_number] => 20120220560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'STEROID TETROL SOLID STATE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/328374
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 43557
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328374
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328374 | STEROID TETROL SOLID STATE FORMS | Dec 15, 2011 | Abandoned |
Array
(
[id] => 9463930
[patent_doc_number] => 20140128357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHODS OF PRODUCING AND USING BRASSINOSTEROIDS TO PROMOTE GROWTH, REPAIR AND MAINTENANCE OF SKELETAL MUSCLE AND SKIN'
[patent_app_type] => utility
[patent_app_number] => 13/993279
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21335
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993279
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993279 | METHODS OF PRODUCING AND USING BRASSINOSTEROIDS TO PROMOTE GROWTH, REPAIR AND MAINTENANCE OF SKELETAL MUSCLE AND SKIN | Dec 12, 2011 | Abandoned |
Array
(
[id] => 8866904
[patent_doc_number] => 20130150607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'New Alkylaromatic Process'
[patent_app_type] => utility
[patent_app_number] => 13/313380
[patent_app_country] => US
[patent_app_date] => 2011-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5751
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13313380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/313380 | Alkylaromatic process | Dec 6, 2011 | Issued |
Array
(
[id] => 8854170
[patent_doc_number] => 20130143845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'VITAMIN D COMPOUNDS AND METHODS FOR ENHANCING MUSCLE STRENGTH, AND PREVENTION AND TREATMENT OF DISEASE IN HUMAN BEINGS'
[patent_app_type] => utility
[patent_app_number] => 13/310999
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12770
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310999
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/310999 | VITAMIN D COMPOUNDS AND METHODS FOR ENHANCING MUSCLE STRENGTH, AND PREVENTION AND TREATMENT OF DISEASE IN HUMAN BEINGS | Dec 4, 2011 | Abandoned |
Array
(
[id] => 8043645
[patent_doc_number] => 20120071562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => '2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses'
[patent_app_type] => utility
[patent_app_number] => 13/302709
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5685
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071562.pdf
[firstpage_image] =>[orig_patent_app_number] => 13302709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/302709 | 2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses | Nov 21, 2011 | Abandoned |
Array
(
[id] => 8822478
[patent_doc_number] => 20130123523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL'
[patent_app_type] => utility
[patent_app_number] => 13/293656
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4134
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13293656
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/293656 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL | Nov 9, 2011 | Abandoned |
Array
(
[id] => 9004720
[patent_doc_number] => 20130225845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'PROCESS FOR PREPARATION OF ESTRADIOL VALERATE AND A NOVEL CRYSTALLINE FORM A OF ESTRADIOL DIVALERATE'
[patent_app_type] => utility
[patent_app_number] => 13/883593
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1793
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883593 | PROCESS FOR PREPARATION OF ESTRADIOL VALERATE AND A NOVEL CRYSTALLINE FORM A OF ESTRADIOL DIVALERATE | Oct 27, 2011 | Abandoned |